Use of EMR Automated FIB-4 as a Tool for MASLD Screening in the Primary Care Setting

Authors

Maria Winte, MD, Thomas Jefferson UniversityFollow
Rebecca Loh, MD, Thomas Jefferson UniversityFollow
Sanjna Shelukar, MD, Thomas Jefferson University HospitalFollow
Ananya Venkatesh, MD, Thomas Jefferson University HospitalFollow
Bryan O'Connell, MD, Thomas Jefferson University HospitalFollow
Dina Halegoua-De Marzio, MD, Thomas Jefferson UniversityFollow

Files

Description

Introduction

• MASLD affects up to 40% of the population in North America and is increasing.
• Screening for advanced fibrosis is now widely recommended, including formal guidelines from the AGA, AASLD, and ADA.
• We implemented an automated Fibrosis-4 (FIB-4) Index for liver fibrosis screening as a tool within our electronic medical record (EMR) to increase screening in patients with risk factors for MASLD.
• Our study examines the impact of this intervention on the appropriate MASLD screening rates among 50–65- year-old patients in the primary care clinic.

Publication Date

10-28-2025

Disciplines

Gastroenterology | Medicine and Health Sciences

Comments

Presented at the American College of Gastroenterology (ACG) Annual Meeting.

Recommended Citation

Winte, MD, Maria; Loh, MD, Rebecca; Shelukar, MD, Sanjna; Venkatesh, MD, Ananya; O'Connell, MD, Bryan; and Halegoua-De Marzio, MD, Dina, "Use of EMR Automated FIB-4 as a Tool for MASLD Screening in the Primary Care Setting" (2025). Division of Gastroenterology and Hepatology Posters.
https://jdc.jefferson.edu/gastrohepposters/7